Furthermore, many modern ADCs feature a “bystander effect,” whereby the membrane-permeable payload can diffuse into adjacent HER2-low or -negative tumor cells, thereby addressing the challenge of tumor heterogeneity (11, 19). Here, ERBB2 is linked to neoplasm.